Aurobindo Pharma reported INR580.8M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Cipla INR 807.78M 17K Mar/2026
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Dr.Reddys Laboratories INR 832.69M 176K Mar/2026
Hindustan Unilever INR 2.35B 409K Sep/2025
Sun Pharmaceuticals INR 2.4B 0 Mar/2026
UPL INR 844.17M 856K Mar/2026